Turks and Caicos Islands

Reimbursed Care Access

The Turks and Caicos Islands maintain a strict statutory control regime over psychoactive substances under the Control of Drugs Ordinance (1976) and recent amendment activity (2024) indicates continued tightening. Most classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are criminalized with no authorised medical or reimbursed access outside of formal, approved clinical research; ketamine is available in clinical settings for anesthesia and emergency care but psychedelic/psychiatric uses are not established as reimbursed standard of care and esketamine (Spravato) has no public record of a local regulatory/listing pathway or reimbursement scheme. [https://www.gov.uk/foreign-travel-advice/turks-and-caicos-islands/safety-and-security|GOV.UK Travel Advice].